PUBLIC HEALTH

Table of Contents



  

PANDEMIC RESPONSE



SARS-CoV-2 TESTING



Do you know the difference between SARS-CoV-2 and Covid-19? Over 90% of adults do not.

  • SARS-CoV-2 is the coronavirus and it is susceptible to antivirals and prevention measures (prophylactics)
  • Covid-19 is the immunological consequence of contracting the coronavirus and it may require treatment
  • Covid-19 severity is measured by hypoxia and biochemical and immunological indicators (CRP, D-Dimer etc)



Since early 2020, the public has been asking: “Why is there no transparency about Covid? Why no open data?”

Why isn’t comprehensive data being collected/made available, despite the calls of medical experts?

There is a criminal failure at the heart of public health management – and it can’t be 100% accidental

Why has there been so little emphasis and such a lack of progress on testing and testing infrastructure from early 2020 to today?

Vaccines help but aren’t 100%. Danger comes from someone infected not someone unvaccinated. What about antigen testing preboarding?

Why won’t anti-vaccine sentiment go away? Why is it intensifying and spreading?



TESTING CONCERNS

  1. Anything less than best possible testing to minimise virus spread 100% risks public health
  2. Lack of honest open data is a big reason millions reject Covid-19 vaccine i.e. they conclude no data equals proof of grift
  3. Lack of testing networks speak to unprecedented confusion or obfuscation in public health authority pandemic management
  4. Anything less than full spectrum testing is perpetuating the virus
  5. Total testing would need to test antibody tiers (IgA, IgM, IgG) and B-cell/T-cell activation (immunological memory)
  6. PCR + antigen (lateral flow) combination testing show both infectiousness and immune system neutralising antibody titers
  7. If testing is not free, testing will happen less for poor/working people, perpetuating the virus
  8. If testing is not standardised, test results will not give consistent data, perpetuating the virus
  9. Some vaccinated (and some unvaccinated) are super-spreaders but there’s no data whether vaccine or natural immunity leads to less infectiousness
  10. Without comprehensive testing protocols standardised and part of coordinated public health response Coronavirus will become endemic


TESTING OBSERVATIONS

  • Proper testing shows up individual infectiousness and/or immunity (neutralising antibodies) to SARS-CoV2
  • Testing is non-discriminatory but if it costs money, it will discriminate against poor/working class
  • Antigen (lateral flow) test very accurate for “am I infectious?” but inferior to PCR for immune system antibody response
  • PCR test doesn’t target infectiousness – which is dumb and defeats the purpose of gateway portal test point mandates (e.g. airports)
  • France and other European countries test for neutralising antibodies (PCR) which is accepted as vaccine equivalent but doesn’t show infectiousness
  • USA vaccine restrictions and vaccine mandate satisfied by proof only, no interest in antibodies, no widespread antigen (lateral flow) test protocols
  • UK testing and travel guidelines take into account immunity (PCR) but make limited use of antigen (lateral flow) at borders


PUBLIC HEALTH TESTING FAILURE

  • Public health independent experts point out transparent open data – simple honesty – is the best way to ensure confidence and overcome vaccine hesitancy
  • Why is there no publicly available data on neutralising antibody levels for natural immunity?
  • Why is there no public data tracking on vaccine-induced immunity (antibody response)?
  • Why is there no public nexus testing (e.g. wastewater) – to reveal outbreaks so public health resources can target efficiently?
  • When there’s a lack of public data it means public health policy is subordinated to political and corporate-profit agenda
  • There’s no public data tracking ongoing testing of antibody/immunity of people from vaccine trials (completions or terminations)
  • There’s no public data tracking cases (infections) unvaccinated, natural immunity, vaccine immunity (2 doses, 3 doses, etc) over time
  • Why wasn’t testing focused on neutralising antibody titers from April/May 2020 as the most effective, useful data before treatment or quarantine/lockdown (or, later, vaccination)?
  • Why do none of the available SARS-CoV-2 testing protocols include the full spectrum of neutralising antibody IgG IgM IgA + aggressive T-cell titers + memory B-cell activation?
  • Daily rapid antigen testing targets minimisation of viral spread, which is what we want eliminated, rather than simply targeting the exclusion of unvaccinated, which won’t necessarily limit viral infections
  • Individual neutralising antibody / infectiousness test results can’t be faked – unlike vaccine certificates or vaccine passports
  • Individual immune system response to vaccine (or prior infection) varies wildly – it defies logic to fixate on ‘got vaccine’ to prevent spread
  • Why is there almost no coherent variant tracking? Why is variant testing left to pooling and extrapolation?


TESTING KIT GRIFT

  • Why aren’t antigen (lateral flow) tests available in the home and at every public portal (airport, venue, office, mall, etc)?

  • Try finding price of an antigen testing kit – very simple, surely?
  • SingClean (on Linkedin) supplies Germany and is authorised by German govt
  • If you’re in Germany you can see prices but not if you’re in the UK or the USA where it’s censored
  • Try searching Ali Baba simply for Covid-19: all results are censored
  • FDA has only authorised Coronavirus test kits as medical devices – effectively creating an impossible barrier to entry
  • FDA approval criteria includes a testing infection period that’s designed to serve market exclusion of antigen (lateral flow) test type
  • FDA medical devices standards ensure only PCR tests can return high accuracy, antigen tests at best 30% accurate by dint of testing only infectious participants
  • This means the only way to get FDA authorisation (EUA) for rapid antigen (lateral flow) tests is to cheat or bribe – hence hardly any antigen tests available in the US and those available sell at 20-50x cost of manufacture


How can it be “Vaccine or Test” when vaccine doesn’t stop infectiousness – and logically it would be “Vaccine AND Test”?

How can a vaccine passport be better than a sufficient up to date negative antigen (lateral flow) test i.e. “not infectious”?

Why do mandates not take a negative Covid-19 test + high antibody score or negative antigen (not infectious) result not equivalent (or better) to vaccination certification?



VACCINE IMMUNITY

  • Given the vaccination objective is to get the immune system to work up antibodies against exposure to Sars-COV2, why’s there no combination of testing infectiousness and tracking of post-vaccine/post-infection antibody response?
  • Shouldn’t that be the basis for vaccine need?
  • Wouldn’t it also create a non-judgmental way to encourage vaccine hesitant to get the shot?
  • Antibody/T-cell/B-cell numbers show who has reacted well to vaccination, who may need boosters, who’s fought off SARS-CoV2 and acquired natural immunity, who may need vaccine despite a prior infection
  • Covid testing (PCR) measures active circulating antibodies, not immunological memory (i.e. long-term immunity)
  • Circulating antibody titers are not predictive of T-cell or B-cell long-term immunological memory
  • Most important, the antibody/T-cell/B-cell immune system numbers show how safe a person is from being infected and/or infecting others with Coronavirus
  • Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections (25-Aug-2021)





SARS-CoV-2 TEST TYPES







PCR TEST

  • The quantitative IgG antibody test selectively detects antibodies directed against the protein S at the spike of the virus. Since all the vaccines currently in use are addressing this specific protein S, the test allows to adequately measure the human immune response resulting from vaccination as well as immune responses resulting from a prior infection. The test can be performed after recovery and any time during the vaccination period but is recommended after 2-3 weeks post vaccination.
  • Cellular immunity tests, on the other hand, isolate immune cells and stimulate them with spike proteins of the virus. This enables measurement of the amount and activity of T-Cells, which are responsible for eliminating ill or altered cells. T-Cells together with antibodies make up the human immune response. Therefore, cellular immunity tests are complementary to antibody tests.
  • COVID-19 Vaccine Effectiveness Test


ANTIGEN (LATERAL FLOW) TEST

  • Antigen test is fast and cheap – less than $1 per test to produce at scale
  • Antigen test isn’t as accurate at detecting immunity but is perfect for testing infectiousness which is what matters in public health


PUBLIC TESTING INFRASTRUCTURE

  • Rapid T-B-nA testing: antigen = lateral flow
  • At home antigen tests for infectiousness
  • Rapid public peer-reviewable results
  • Judiciously placed testing points (e.g. at schools, malls, public transport interchanges, etc)?
  • Free testing as a public health priority
  • Free treatment if testing results show infection and high risk
  • Proper testing has 100% demonstrable benefits
  • Proper testing has no downside except cost to government and shifting the needle away from purely political public health policy


WHO PAYS?

  • Polling shows even the vaccine hesitant are not against regular testing if it’s free and especially if it’s a test they can take at home
  • In economic terms, testing is surely cheaper than potentially bankrupting disruption of sledgehammer lockdowns – cost benefit analysis makes this clear
  • The major difference between focus on testing and fixation on lockdown is who pays: testing is a govt expense, lockdown expense hits the citizen/business


PANDEMIC CLARITY

  • How can there be no pandemic test-and-trace – or at least test-and-advise – protocol?
  • Coronavirus outbreaks are reduced to zero if the R (infection rate) is below 1 – target doesn’t have to be zero
  • Waste water testing should be ubiquitous
  • The UK authorised and distributed antigen tests for free to everyone
  • How can governments (and institutions) argue endlessly over mask mandates in schools, vaccinating children, lockdowns, freedoms curtailed, quarantines, travel restrictions, when these could be settled by an open, logical, follow-the-data decision making?
  • Pool testing is unnecessarily vague yet it’s US standard – almost as if it’s trying to prolong pandemic by deindividuating positive Covid-19 testing
  • FDA/CDC public health refuses at home antigen testing because “it might change behaviour” – a pre-Covid standard – but what about pregnancy kits?
  • Testing doesn’t need to be welded to tracking if the link creates public discontent
  • There’s a wilful repetition of the presumption testing must always include tracking that’s too consistent to be accidental
  • Test-and-trace (instead of simply comprehensive T-B-nA testing) distracts public scrutiny away from REAL government failure (or refusal) to fund simple provision of comprehensive testing infrastructure by instead stoking fear of future abuse (tracking surveillance)





ARTICLES



PANDEMIC RESEARCH



 

CORONAVIRUS IMMUNITY



BASIC POINTS ON IMMUNITY

  1. Prior infection and Covid-naive vaccination and vaccination after recovery from Covid-19 can all reduce risk and levels of SARS-CoV-2 infection
  2. Vaccine immunity – and to a lesser extent natural immunity – protect to varying degrees depending on the continued mutation evolution of variants
  3. Vaccines and prior infection will accelerate viral clearance even if infected
  4. Fully vaccinated individuals with breakthrough infections have peak viral load similar to unvaccinated cases and will efficiently transmit infection, including to fully vaccinated contacts
  5. Host–virus interactions early in infection may shape the entire viral trajectory including amount of SARS-CoV2 viral exposure and individual immune system factors


EXPOSUREINFECTIONRECOVERYRESISTANCE

  • Exposure: if you are exposed to a lot of SARS-CoV2 it will infect you and could hit you hard (symptoms, Covid-19 severity)
  • Infection: including symptoms and Covid-19 severity – will be reduced in severity by vaccine and past immunity (i.e. by neutralising antibodies and immunological memory)
  • Recovery: if you’re hit hard by Covid-19, the silver lining is high level of long-lasting antibodies and immunological memory, i.e. potentially long lasting resistance
  • Resistance: if you’re exposed to SARS-CoV-2 and it infects you but your natural or vaccine immunity clears the virus quickly, the downside is lower level of priming of immune system against future coronavirus


IMMUNE SYSTEM: 5 ANTIBODY TYPES

  1. IgA. IgA antibodies are found in areas of the body such the nose, breathing passages, digestive tract, ears, eyes, and vagina. IgA antibodies protect body surfaces that are exposed to outside foreign substances. This type of antibody is also found in saliva, tears, and blood. About 10% to 15% of the antibodies present in the body are IgA antibodies. A small number of people do not make IgA antibodies.
  2. IgG. IgG antibodies are found in all body fluids. They are the smallest but most common antibody (75% to 80%) of all the antibodies in the body. IgG antibodies are very important in fighting bacterial and viral infections. IgG antibodies are the only type of antibody that can cross the placenta in a pregnant woman to help protect her baby (fetus).
  3. IgM. IgM antibodies are the largest antibody. They are found in blood and lymph fluid and are the first type of antibody made in response to an infection. They also cause other immune system cells to destroy foreign substances. IgM antibodies are about 5% to 10% of all the antibodies in the body.
  4. IgE. IgE antibodies are found in the lungs, skin, and mucous membranes. They cause the body to react against foreign substances such as pollen, fungus spores, and animal dander. They are involved in allergic reactions to milk, some medicines, and some poisons. IgE antibody levels are often high in people with allergies.
  5. IgD. IgD antibodies are found in small amounts in the tissues that line the belly or chest. How they work is not clear.


IMMUNE RESPONSE



VACCINE IMMUNITY

  • Vaccines infection generates IgM then IgG antibodies but doesn’t promote antibody IgA or long-term immunological memory
  • Vaccine immunity is waning over time (3-6 months plus) and also losing efficacy as variants evolve
  • Vaccine immunity focus is on spike protein not other aspects of SARS-CoV-2 hence narrow but strong specific antibody response
  • Immunity from vaccination + prior symptomatic infection = high level short-term antibodies IgM IgG and IgA and long-term immunological memory IgA
  • Vaccine efficacy and natural immunity vary greatly between individuals and by viral load exposure, severity of past Covid-19, SARS-CoV-2 variant
  • mRNA vaccine causes higher short-term immunity response to coronavirus but wanes after 3-6 months
  • adenovirus vector vaccines not as high  as mRNA short-term but as a more traditional mechanism the protection wanes slower
  • Vaccination is effective for 3-6 months after double/boosted dose (in sampled participants):
  • Vaccination primes the circulating antibodies IgM and IgG against SARS-CoV-2 spike protein – positive titers from vaccine is well proven


NATURAL IMMUNITY

  • Symptomatic infection from Covid-19 creates substantial natural immune memory across all kinetics
  • Natural immunity is giving cross immunity to successive variants so far from alpha to Omicron
  • About 95% of subjects retained immune memory at ~6 months after infection i.e. natural immunity
  • Natural infection provides immunity to SARS-CoV2 – extent of antibody response depends on severity of infection
  • Natural immunity lasts longer but short-term may not be as strong as vaccine immunity
  • Natural (prior infection) immunity can be combined with vaccination
  • Documented cases of unvaccinated with prior Covid-19 infection (natural immunity):
    • Estimated efficacy 94·8%
    • Hospitalisation prevention 94·1%
    • Severe illness 96·4%
  • MoH Summer Surge Data:
    • Between 5 July and 3 August over half a million infected but unvaccinated
    • 1% of weekly new cases were in people who had previously had Covid-19 (natural immunity)
    • Antibodies against SARS-CoV2 spike and receptor binding domain (RBD) declined moderately over 8 months
    • Memory B cells against SARS-CoV2 spike increased between 1 week and 8 weeks after infection
    • Proportion of subjects positive for CD4+ T cells (92%) remained high at 6 to 8 months after infection


ARTICLES / STUDIES





PUBLIC HEALTH COMMENTS

  • Dvir Aran, Technion“These numbers look very low. The data suggest that the recovered have better protection than people who were vaccinated.”
  • Peter Marks, FDA“We know that the immunity after vaccination is better than the immunity after natural infection.”


STUDY DATA

  • Natural infection data (USA Feb 2020 to May 2021):
    • 0 – 17     26.8 / 73    37%
    • 18 – 49   60.5 / 138   44%
    • 50 – 64     20.4 / 62    32%
    • 65+ 12.3 / 54    23%
    • Total 120.3/ 328   37%
    • N = 254 blood samples post infection
    • N = 51 long term follow up
    • Antibodies against SARS-CoV2 spike and receptor binding domain (RBD) declined moderately over 8 months
    • Memory B cells against SARS-CoV2 spike increased between 1 week and 8 weeks after infection
    • Proportion of subjects positive for CD4+ T cells (92%) remained high at 6 to 8 months after infection


We found that Spike antibodies showed better durability than Nucleocapsid antibodies. During the first six months, spike antibodies also showed better durability (half-life 97 days) than the subset of Spike-RBD antibodies (half-life 62 days), whereas both Nucleocapsid and N-RBD antibodies showed similar persistence (half-life 47 days). Similar conclusions were drawn in a study by Fenwick et al. [42] who reported differential waning of SARS-CoV-2 humoral responses, with antibodies recognizing the trimeric Spike being more persistent compared to antibodies recognizing nucleocapsid. The analysis of our cohort revealed a bi-phasic decline of antibodies with an inflection point at ~6 months post symptom onset.



MASKS AND VENTILATION



PUBLIC POLITICS

  • 18+ months into pandemic, how can there be no definitive public health protocols for mask use?
  • Why is there so little thorough study data on masking, mask policy or airflow viral load?
  • Why has the study of masking been allowed to be a merely political / civic law enforcement wedge issue?
  • Public health should be organised as a medical issue regardless of which “team” is in power
  • There should surely be no uncertainty about these basic issues of public health
  • The next pandemic may be worse


MASK AND FILTRATION FACTS

  • Cloth, silk and other fabric masks are not effective
  • Studies show unequivocally: any mask below N95 rating is not useful against SARS-CoV-2
  • Air filtration systems are exponentially more effective than masking using current widely available technology
  • Planes have filtration systems running the air with over 99% effectiveness at removing airborne (aerosol) particulates
  • HEPA air filtration (as on planes) is the equivalent of permanently worn N99+ mask


MASK POLICIES

  • USA: California, New York City, Florida, Colorado, Seattle, Oregon
  • UK: England, Scotland, Wales, Northern Ireland, Gibraltar
  • EU: Germany, France, Austria, Spain, Portugal, Italy, Poland, Hungary, Holland
  • Global South: Brazil, Argentina, Chile, Australia, New Zealand, South Africa
  • Asia: India, China, Taiwan, Japan, South Korea, Israel, Russia, Pakistan, Singapore, Malaysia, Indonescia


COVID-19 PROTECTION IN PUBLIC/HIGH-RISK SPACES

  • Studies show cloth masks are not effective – anything below N95 is ineffectual
  • PPE for COVID-19 must include, at minimum, N95 respirators or higher, isolation gowns, i.e. standard surgical clothing
  • Surgical and non-respirator face masks do not protect persons from aerosolised or airborne infectious diseases and cannot be relied upon for novel pathogens such as COVID-19 over air filtration and – if high-risk exposure – N95+ face masking
  • Examples of N99+ mask include: powered Air-Purifying Respirator (PAPR) with high efficiency particulate air filters as protection against aerosol generating procedures on suspected or confirmed COVID-19 cases like ventilated patients
  • Open and continuous communication about any potential exposure to suspected or confirmed COVID-19 cases
  • Screening protocols to identify patients who may have COVID-19 infections
  • Plans to ensure prompt isolation of patients with suspected or confirmed COVID-19 infections in airborne infection isolation rooms
  • Protective PPE for nurses and other health care workers providing care to patients with suspected or confirmed COVID-19 infections including airborne and contact precautions
  • PPE for COVID-19 must include, at minimum, N95 respirators or higher, isolation gowns, eye protection, and gloves
  • OSHA recommends that if N95 respirators are not available, employers should use higher levels of respiratory protection such as N/P/R100s, elastomeric respirators, powered-air purifying respirators, and others
  • A Powered Air-Purifying Respirator (PAPR) with high efficiency particulate air filters must be worn during aerosol generating procedures on suspected or confirmed COVID-19 cases
  • All donning and doffing should be performed in a separate room, with a buddy system to ensure efficacy and hands on training
  • 14 days paid precautionary leave for a nurse or other health care worker who is exposed to COVID-19 – ended with two negative antigen tests (1-2 days apart)
  • Exposure incident procedures: Employers must identify, evaluate, and investigate potential worker exposures including techniques like wastewater testing – locally managed medical and testing follow-up services must be provided, free of charge, to all exposed employees


VENTILATION INFO



ARTICLES / STUDIES



TREATMENT AND PROPHYLAXIS



Why is there zero definitive info on medical prophylaxis?

Why no policy on individual prevention?

Why no open debate on evolving treatment protocols?



OBSERVATIONS

  • Much talk about cases of damage from the spike protein post-vaccine but reasons have been hard to pinpoint. Could it be down to not asperating the needle prior to injection, and thus occasional inadvertent injection of the vaccine into the bloodstream – which is known to be extremely dangerous?
  • How many who’ve had the vaccine got their needles aspirated?
  • Why would there be aggressive, partisan exclusion of ANY prophylactic that’s cheap and universal and proven safety record?
  • Amplifying overdose victims is propagandist; never sincere.


CONSIDERATIONS

  • Vaccine gives (high estimate) 90% protection from SARS-Cov2
  • Ivermectin prophylactic + treatment inclusion adds 0%-5% protection (i.e. it is useless or it is a bit useful)
  • End result potentially saves tens of thousands of lives WITH the antiviral versus withou
  • No downside to using all possible probable non-harmful preventions,m treatments, etc
  • Where’s the medical logic in banning ivermectin or predisposing against any medication promising even a single percentage better outcome likelihood?
  • Regeneron makes REGEN-COV: a mixture of two monoclonal antibodies: casirivimab and imdevimab
  • “[Regeneron] is an important treatment before you get to the hospital” Dr Nancy Foster, President Travis County Medical Society
  • “It must be given before symptoms worsen to the point of a patient being hospitalized. If you show up to the ER short of breath, it’s too late” Dr Scott Clitheroe, Travis County Medical


PREVENTATIVE and EARLY TREATMENT

  • Is the dosage level required to get enough ivermectin into play for anti-Sars-CoV2 viral replication significant? Because Pfizer’s last line of defense for its ritonivir combo drug (that works like ivermectin) is it needs a much lower (safer) dosage to be effective as an anti-SARS-CoV2 protease inhibitor
  • Where’s the medical logic in banning ivermectin or predisposing against any medication promising even a single percentage better outcome likelihood?
  • Could this be because while Ivermectin inhibits many mechanisms (as you’ve reported), this makes it less effective – by dose – against any one specific mechanism? Might this require higher dose Ivermectin to be as effective as Pfizer’s Paxlovid, which targets only one mechanism?
  • (Even though obviously the Pfizer drug is far more likely to become resisted by viral mutation as it is single mechanism rather than Ivermectin’s multiple mechanisms of action)
  • Is the dosage per mechanism significant? I’ve not yet found a paper answering this question!


INTERVENTIONS

  • VITAMIN D



TREATMENT PROTOCOLS



TREATMENT ARTICLES





VACCINES AND MANDATES



VACCINE TYPES



VACCINE PROS AND CONS

  • Reduces likelihood of hospitalisation (and worse) for elderly, comorbidities and immunocompromised – which is the majority of the population
  • Vaccine efficacy against Covid-19 – especially hospitalisation and life-threatening complications – remains demonstrable even for young people, unless specifically at risk
  • Antibody levels in part come from extent of viral load exposed
  • Passing natural infection might engender lower antibodies than a double or triple (i.e. regular) dose of vaccine
  • Natural immunity is absorbed into long-term B-cell memory as mRNA inspired response does not
  • Systemic side-effects from vaccine especially mRNA vaccine more common in people previously infected
  • Science by Press Release is never honest
  • Vaccine immunity is demonstrated neutralising antibodies IgM/IgG but less convincing on IgA and long-term immunological memory B-cell stimulation
  • Vaccines tend to give more definitive high equivalent viral load so can stimulate less variable IgM/IgG antibody and some T-cell response than – for example – low viral load natural exposure


VACCINE SIDE EFFECTS

  • Large UK study of systemic/vaccine side effects after natural infection:
    • 1·6 times after the first dose of ChAdOx1 nCoV-19
    • 2·9 times after the first dose of BNT162b2
    • 56% more likely to experience a severe side effect that required hospital care


ADVERSE REACTIONS



VACCINES FOR YOUNG AND OLD

  • Vaccination seems to reduce likelihood of hospitalisation (and worse) for elderly, comorbidities and immunocompromised but needs boosters every 6-12 months
  • Vaccines probably reduce likelihood of severe illness including hospitalisation and death for young and middle-aged versus naive natural infection – 3-6 months after most recent vaccination
  • Young have greater absolute risk from vaccination versus older people though risk is very low (under 1%) across all agees
  • Older people and immunocomprimised people much higher risk from Coronavirus
  • Severe illness including hospitalisation and death exponentially higher impact by comorbidities (including being fat, low Vitamin D) than vaccine status
  • Young people recover fast
  • Young males risk greater from mRNA vaccination than from Covid-19
  • Should young people be forced to take the individual risk for the sake of older, vulnerable members of the public?
  • Myocarditis young – especially young males – incident percentages higher than simply catching Covid and higher than baseline – possibly lack of aspiration?
  • Incidents of myocarditis and pericarditis in Norway (no aspiration) 240% higher than Denmark (aspiration) same vaccine, same 90%+ vaccinated population
  • Vaccine efficacy press release 2020: overall efficacy 92·8% | prevent hospitalisation 94.2% | prevent severe illness 94.4% | prevent death 93.7%


VACCINE MANDATES



PATENT SHARING

Pfizer/Moderna (i.e. NIH – as patent holder) aren’t sharing their vaccine recipe because they need to protect the mRNA platform, quite separately from the debate over proliferating vaccination against SARS-CoV-2 in the context of saving lives in the Coronavirus pandemic.
It’s possible the big pharmaceutical corporations don’t object to letting poor countries make their own vaccines. The problem is with sharing the mRNA platform itself – specifically – because it is a multipurpose technology way beyond targeting spike proteins with potential for revenue streams that dwarf the billions made from SARS-CoV-2.
The mRNA platform has myriad uses as a cancer delivery drug, which is perhaps the biggest prize in medical science – a bonanza of incalculable trillions that could roll on and on for decades. This is why the patent isn’t going to be shared. It won’t be shared until the technology can be shared in a way that doesn’t open access beyond targeted Coronavirus usage. The vaccine corporations will doubtless be working on a nerfed version. If they find it, there will be a fanfare of “patent sharing”.


VACCINE DEVELOPMENT PAPERS


PHARMACOLOGIES


Bioscience Tech


AD-VECTOR Tech (AstraZeneca)


mRNA Tech (Pfizer, Moderna)



ARTICLES





PUBLIC HEALTH RESPONSE



PANDEMIC RESOLUTION



DATA PUBLISHING

  • Coronavirus disease 2019: The harms of exaggerated information and non-evidence-based measures (19-Mar-2020)
  • Infections is the number/trend generating most of the headlines in the media and on the news:
    • It is partly indicative of a rise or fall in SARS-CoV-2 prevalence
    • But frequently number of infections fluctuates according to how many tests are being sampled
    • Health authorities keen to justify lockdown or more vaccine take up will ramp up testing to generate higher infections so it looks like a sudden spike
    • Conversely health authorities trying to look effective and on top of Coronavirus will reduce testing so it suddenly looks like the virus is on the way out


NO COMPLETE PICTURE IS EVER PROVIDED TO THE PUBLIC OR THE HEALTH AUTHORITY

  • New infectious are front page news, hospitalizations and deaths are regularly cited in prominent graphics but the circle is never squared by recording (and reporting) recovery alongside infected
  • An infection (case) is a key data point but it needs a virus cleared (recovered) data point too
  • But at population scale, new positive tests (infections/cases) need follow-up negative tests (recovered, virus cleared) to make useful public policy
    • Length of time between infection and recovered
    • Provides public # of active infections – i.e. virus prevalence – across a given population, county, outbreak area, etc
    • Opens potential for analysis of natural v vaccine immunity in speed of viral clearance, severity of disruption
    • Builds coherent non-pharmaceutical corporate trial data on antibody titer levels and impact of virus duration on subsequent immunological response
    • Gives public health authorities a direct line on assessing new variant behaviour (e.g. highly infective, mild symptoms, quick to clear or low infection rates but aggressive once it takes hold)
  • Hospitalisations listed under Covid-19 are 75% hospitalized for other reasons antigen/PCR testing positive for SARS-CoV-2 after admission
  • Variability in death-by-Covid records because half the records list as “death by Coronavirus” anyone who tests positive when kicking the bucket
  • Whereas half health authorities only record as a “death by Coronavirus” if the death is caused by Covid-19 directly


  • COVID PUBLIC HEALTH DATA

    “The Great Barrington Declaration” is signed and published in Great Barrington MA (USA) (Kulldorff, Gupta, Bhattacharya 4-Oct-2020) – “As infectious disease epidemiologists and public health scientists we have grave concerns about the damaging physical and mental health impacts of the prevailing COVID-19 policies, and recommend an approach we call Focused Protection”



    How do we beat the Coronavirus pandemic?

    1. Minimise Covid-19 casualties
    2. Temporary social disruption
    3. Support against economic damage (especially to small business)
    4. Protect psychological damage to parents and children
    5. Reduce SARS-CoV-2 direct and corollary impact on healthspan?




    VACCINE

    • All vaccine programmes must include properly tracked – with an opt out – no mandates
    • ASPIRATION
      • Why is there no official protocol for aspirating before injection of vaccine, to ensure none of the vaccine is intravenous?
      • Aspirating ensures vaccination goes intramuscular, not intravenous because intravenous is dangerous
      • Intravenous doesn’t happen often but it is more common in younger people and warned against by vaccine makers
      • Lack of aspiration is the prime candidate for what could be causing the relatively rare but nonetheless real adverse reactions
      • Significant incidents of post-vaccine myocarditis, thrombosis and other extreme adverse reactions to the mRNA vaccines in particular
    • Because pharmaceutical is immune from prosecution, government is caught in its own trap: it can’t change advice to include aspiration because doing so would admit an astronomical class action by thousands of vaccine injured
    • End result of the government covering itself is no change to aspiration advice which directly leads to unnecessary death and suffering (and fuel for vaccine hesitancy)
    • MEDICAL ADVERSITY
      • Guilt and negligence aside, government must adequately fund full adverse injury cover – especially if big pharmaceutical companies continue to be protected from all liability
      • Lack of government sponsored cover for Covid-19 and vaccine adverse effects (injury) is one of the main reasons millions choose to stay unvaccinated
      • Contrary to the public messaging vilifying wilful ideological rejection of vaccine, over 75% of unvaccinated are working and precarity classes – disproportionately ethnic minorities, often without a doctor or medical cover


    TESTING

    • Proper testing (with opt-out on tracking) and fast response to positive tests: antigen in every home

    DOCTOR – PATIENT PROPHYLAXIS

    • Unshackled doctor-prescribed prophylactics and other treatments per doctor patient relationship
    • Particular care for immunocompromised people in particular with a full range of prophylactics

    MASKS AND VENTILATION

    • Encourage mask use on public transport and indoor spaces but optional; antigen testing at every threshold
    • HEPA filtration systems on all enclosed public transport and underground stations/terminus

    DATA SCIENCE

    • Open data – no censorship – no patrician ‘lies for the perceived public good’
    • Full tracking of public antibodies and immunity using PCR testing – especially post-vaccine post-infection
    • Vigilant public health measures like wastewater testing, resources targeted on outbreaks


    STATE AUTHORITY – MANDATES

    • The Significance of the Nuremberg Code
    • No mask mandates – no vaccine mandates
    • No lockdown – no forced community quarantine
    • No closure of business – no curfew – no state-sponsored violence against the citizen
    • No travel restrictions but antigen testing at every travel portal
    • Public portal antigen protocol: shops, offices, venues, airports, stations, schools, churches, etc
    • No vaccine passports – no coercive threat-to-income compelled behaviour

    PUBLIC HEALTH MESSAGING


    BAD FAITH

  • Monopoly on science on my side only – ignorant heresy to dispute my orthodoxies
  • Ad hominem attack to discredit heterodox opinion is dishonest and counter-productive; and evades taking on the real substance
  • Money matters – everybody knows this – so obfuscating profit motives undermines faith
  • Health and medicine science is not political – everybody knows this – so every time messaging conflates asserting fact with obvious politicisation it will alienate


  • ECONOMIC GOOD GOVERNANCE





    PUBLIC HEALTH OBJECTIVES

    • Minimise SARS-CoV-2 incursion, spread and longevity in the population
    • Encourage robust immunity to SARS-CoV2 across the population
    • Encourage focus on reducing comorbidities
    • TACKLING COMORBIDITIES
      • Why no public health messaging on tackling known comorbidities like weakened immune system or obesity etc?
      • Why is there no broadcast messaging about immune system healthiness, like Vitamin D, Zinc, obesity, smoking, judicious diet, fitness, or proven cheap Covid-19 prophylactic nasal spray/eye drops?
      • It makes no medical sense whatsoever not to frontline these easy personal interventions likely to save tens of thousands of lives (at the very lowest)
      • Vitamin D and the Immune System (Aug-2011)
      • Vitamin D Prevent Acute Respiratory Tract Infections: Systematic Review (15-Feb-2017)
      • Individual health and individual immune system aids: vitamin D, Zinc, weight loss, less smoking, cardiovascular exercise, etc
      • CDC: Obesity, Race/Ethnicity, and COVID-19


    PROTECTION AGAINST COVID-19

    • Advise all reasonable metrics known to increase protection against Covid-19:
      • Test portals
      • Air filtration interiors
      • Free antibody-appropriate vaccination
      • Doctor access to unrestricted antivirals
      • Concordant reduction efforts against co-morbidities
      • Public advisories on strengthening immune system, citizen trust: antigen tests in every household + isolate when positive antigen with no isolation if/when double negative antigen, community wastewater testing


    NATURAL v VACCINE IMMUNITY

    • Immunity and immunological memory following smallpox vaccination (2-Nov-2006)
    • METRICS
      • Antibodies (IgG, IgM, IgT, IgA) against SARS-CoV2
      • Stimulate memory B-cells
      • Educate killer T-cells
      • Reduced SARS-CoV2 viral load
      • Shorten period of SARS-CoV2 infectiousness
      • Faster viral clearance
      • Long-lasting multiple vector antibody titers against future exposure
    • OBSERVATIONS
      • Unvaccinated with no natural immunity look most likely to be hospitalised by severe Covid-19
      • Covid-19 deaths appear to be higher percentage among unvaccinated without natural immunity
      • Therefore natural immunity and vaccine immunity reduce severity of Covid-19
      • Some evidence supports vaccination giving 3-9 months less likely to be hospitalised, less likely to die
      • Contracting Covid-19 is more dangerous than aspirated vaccination as a way to prime immune response


    TO VACCINATE OR NOT TO VACCINATE?

    • Vaccination gives non-trival boost to antibody immunity against SARS-CoV-2 variants without the risk of contracting the virus
    • Natural immunity from infection is broader, more potent and more long-lasting than immunity from vaccine
    • Natural immunity depends on the viral load of infecting exposure
    • Risks to most people – especially elderly, immunocompromised and co-morbidities – from Covid-19 outweigh natural immunity from naive exposure
    • Recovering from the virus gives 8x-12x level of short-term and long-term antibody immunity
    • SARS equivalent immunity has lasted 10+ years
    • mRNA vaccine immunity is shown to wane considerably after 6 months
    • Is it OK to put young lives at greater risk for the sake of older lives potentially facing greater risk, e.g. coronavirus caught by grandkids passed on to grandparents?
    • CDC data shows very very low risk from Coronavirus vaccines (mRNA or ad-vector) though the chance of serious side effects increases – separate to co-morbidities – for much younger patients, especially males under 21
    • CDC site numbers give between 5000-1 and 20000-1 serious myocarditis/pericarditis risk for mRNA (Pfizer/Moderna) vaccines, especially after second dose
    • This risk is far higher than the risk of serious Covid-19, for that age/gender group
    • Myocarditis and Pericarditis Following Vaccination with COVID-19 mRNA Vaccines in Ontario: 100 Youths Hospitalized after mRNA Vaccination (13-Dec-2020 to 7-Aug-2021)




    CIVIC CONTRAINDICATIONS



    CONTRARIAN EXPERTISE



    THE GREAT BARRINGTON DECLARATION

    • “The Great Barrington Declaration” is signed and published in Great Barrington MA (USA) (4-Oct-2020)
    • “As infectious disease epidemiologists and public health scientists we have grave concerns about the damaging physical and mental health impacts of the prevailing COVID-19 policies, and recommend an approach we call Focused Protection”
    • The declaration rejects current [2020] handling of public health response to the pandemic
    • By October 2021 signatories and supporters are a de facto medical alliance – the largest expert movement of its kind since the Second World War
    • Great Barrington Declaration is authored by three of the world’s pre-eminent epidemiologists with key vaccine and public health expertise:
      • Dr Martin Kulldorff (Harvard University)
      • Dr Sunetra Gupta (University of Oxford)
      • Dr Jay Bhattacharya (Stanford University Medical School)
      • (plus thousands of doctors across the world at every level of medical care and research)
    • NIH Directors Fauci and Collins Target the Great Barrington Declaration (18-Dec-2021)

    NON-AUTHORITY DOCTOR PROTOCOLS



    CONTRARIAN SITES


    COUNTER NARRATIVE ARTICLES





    CONTRARIAN MEDIA





    VIDEO CONTENT



    Peter McCullough – Children’s Health Defense – Medical Advisory


    Dr Peter McCullough ‘Therapeutic Nihilism And Untested Novel Therapies’ | RUMBLE VIDEO (5-Oct-2021)


    Professor Mattias Desmet talks about his work that connects past historical episodes of what is called “Mass Formation” (aka Mass Psychosis) and Coronavirus (3-Dec-2021)





    “As a now triple-vaxxed person who has had the virus previously I am intent on living my life as normally as possible, which includes not unduly worrying about it or demanding others do so. And I would argue that expecting otherwise from me would make you functionally an anti-vaxxer.”



    World Health Organization Annual Influenza:



      

    CORPORATE STATE



    Trust – Social Contract – Public Private Bioscience



    Why has public trust in government/media broken down? How can it be restored?

    • Why is government official guidance allowed to devolve into such useless disingenuous binaries?
    • Authoritarian binaries are idiotic and destroy public faith in institutions and institutional narratives
    • No party political narratives should exist in a pandemic
    • Debate by public figures (not politicians) is coarsened to the point of alienation whenever political rhetoric (slogans, ad hominem, wilful misinterpretation, gotcha spin) is used instead of civil, shared truth-seeking
    • Trust is shattered by god-complex celebrity front-men (like Anthony Fauci) with compromised (and even corrupt) conflict of interest (private enrichment) – personal fame is incompatible with public duty
    • Vaccine versus anti-viral is a case in point. It’s not either vaccination or antiviral/alternative treatment. It’s both. It’s all of the above.
    • Measures to prevent spread (testing, isolation, lockdown) and infection by SARS-CoV-2 (vaccine, antiviral) are not the same as measures to treat Covid-19 (monoclonal antibodies, fluvoximine)
    • Statewide mandates restricting informed doctor-patient freedom of choice ensures both a fait accompli of outlier overdose while excluding billions (including those with no vaccine access) from best possible outcomes; not to mention demoralising the medical profession at a time it needs to be supported
    • Why is there so much dehumanising rhetorical and systemic pressure on the vaccine ‘hesitant’ to comply, but never anything substantial that might cost money, like a year’s free aftercare in the event of adverse reaction?
    • Fixation on compliance turns a public health choice into a loss of freedom fear, for much of the general public – why perpetuate this?
    • Vaccine makers are shielded from consequences in the event of negligence – how can this help public trust?
    • Why is there no quid pro quo support for workers who submit to testing and adhere to restrictions if infected (e.g. self-isolating), to cover loss of essential earnings?
    • Former HHS officials say they tried to accelerate funding for what became Merck’s new “miracle” drug last year, but were blocked by the NIH
    • Culture-war stupidity may have cost “tens of thousands” of lives
    • Who Actually Owns Corporations Anyway? (22-Dec-2021)
    • What to know about the Coronavirus and Blood Donation by American Red Cross (Aug-2021)
    • “In most cases, there is no deferral time for individuals who received a COVID-19 vaccine as long as they are symptom free and feeling well at the time of donation. There is no deferral time for eligible blood donors who are vaccinated with an inactivated or RNA based COVID-19 vaccine manufactured by AstraZeneca, Janssen/J&J, Moderna, Novavax, or Pfizer”


    VACCINE LIABILITY



    END JUSTIFIES MEANS?

    • The tangled history of mRNA vaccines (14-Sept-2021)
    • Can the end justify the means when it come to public health, i.e. saving the most lives versus respecting individual freedom (to be wrong)?
    • What if the end is profit and the means is public health management?
    • Why is an anti-viral like Ivermectin pilloried as a “horse paste” – in such a blatantly propagandist, divisive way – despite its clear usefulness as a prophylactic?
      • Antivirals like Ivermectin disrupt viral replication, i.e. its effectiveness is against SARS-CoV-2 (prophylaxis) not Covid-19 (treatment)
      • As SARS-CoV-2 spread it may cause Covid-19 (respiratory disease &c) which is a critical distinction
      • Emphasis on antiviral as failing as a treatment is dishonest if it’s in a study or by a medical expert because they know the difference between SARS-CoV-2 virus and Covid-19 disease
    • Some cite lack of quality data on anti-virals like Ivermectin as a reason for its aggressive exclusion from SARS-CoV-2 protocols.
    • Why wasn’t Ivermectin trial’d aggressively from early 2020, as a repurposed antiviral against SARS-CoV-2?
    • Why are there so few studies and such active suppression of repurposed drugs (cheap, readily available, proven safety record)?
    • The NYT’s Partisan Tale about COVID and the Unvaccinated is Rife with Sloppy Data Analysis (1-Oct-2021)
    • Let’s all Mask Up Until We Reach Herd Immunity (23-Dec-2021)





    CONTRADICTIONS, SUSPENDED DISBELIEF AND HYPOCRISY

    • Masks
    • Funding research
    • Price gouging
    • Emergency Use Authorization monopoly
    • Clinical trial corruption
    • Breach of Nuremberg Code
    • Wealth transfer from bottom to top
    • Authoritarianism
    • Obdurate orthodox messaging misinterpretation


    BIG PHARMA – REGULATORY CAPTURE – SCALE DOMINANCE



    • Why so little attention given – especially from Summer 2021 – to data showing the ad-vector vaccine antibody response is lasting considerably longer than the Pfizer/Moderna mRNA shots?
    • Is the rapid loss of SARS-CoV2 neutralising antibodies (immunity) from – in particular – the mRNA vaccines contributing to the persistent and otherwise inexplicable low fidelity testing standards?
    • Why is AstraZeneca vaccine not available in the US, even after its proven safe, used in comparable countries with better Coronavirus outcomes?


    Is it possible for Big Pharma profit to coexist with best public health outcomes?



    BIG PHARMA CORPORATIONS

    • Moderna (m—-RNA) in Cambridge MA start-up launched to monetize public-private partnership
    • Pfizer exclusive partnership with German funded BioNTech
    • AstraZeneca licenses Oxford University developed vaccine for Coronavirus with a zero-profit agreement


    PROFITS

    • Big Pharma, having already entered into contracts to deliver billions of vaccine doses, spends millions on the groundwork:
      • in mainstream media
      • government manipulation
      • health authority (CDC, FDA, NHMI, PHE, etc
      • advertising
      • funding studies to serve maximum profit
      • guide public pandemic expectations
    • Pharmaceutical corporations achieve unprecedented demand from national vaccine programs across the world
    • Pfizer and Moderna (in particular) are focused on harvesting hundreds of billions of dollars profit
    • Boosters and – in their ideal world – lifelong every 6-12 months compulsory vaccination equals trillions of dollars


    LIMITED LIABILITY



    TRILLIONS

    • Trillions of dollars are at stake
    • Spread of revenue for business, corporations, health regulators and government/treasury
    • Lion’s share of revenue heading for Wall Street and City of London shareholders in big pharma
    • Medicine hegemony in the United States, the UK and India (as the biggest vaccine manufacturer)
    • This hegemony of profit-share will ensure American/UK govt and its corporate clients will continue to exert their tight hold on the Coronavirus regulation (ppatents) on behalf of pharmaceutical corporations (profit engines) and health authorities (funding distributors) coordinated by Gates Foundation/Wellcome Trust (source of over 60% global money in all medical and biotech)


    COST/PRICING



    INSURANCE AND SICK LEAVE



    VACCINE DATA – TRIALS – EFFICACY – APARTHEID



    Development of mRNA technology has been in progress for over 20 years, primarily with a view to opening a new deliver mechanism and drug potential for cancer treatments. Various science hurdles had to be overcome; and NIH / DARPA funding drove the research in the US. UK and German government funding equivalents, both importing the technology once the patented messenger RNA delivered in lipid shell mechanism was patented by US Govt. NIH licensed the mRNA tech to public/private companies like BioNtech, Moderna, Cellscript and others.

    While mRNA was originally found to be viable for in vivo gene transfer in the early 1990’s, the development of mRNA vaccines was initiated much later due to the inherent instability of mRNA compared to DNA. The efficacy of mRNA vaccines can be increased by several factors, such as ensuring mRNA purity, adding 5’ Kozak and cap sequences, 3’ poly-A sequences and modified nucleosides to increase mRNA stability and decrease detection by the receptors of innate immune cells, codon optimization, introduction by intramuscular, and intradermal injection to reduce RNA degradation, and by generating thermostable mRNA. Methods to encapsulate RNA have also been explored to increase the stability and immunogenicity of RNA vaccines, as has been used with exosome encapsulated RNA and RNA-transfected dendritic cells. When fully optimized, RNA vaccines may have an immunogenic advantage over DNA vaccines due to the presence of multiple cellular pathways that activate innate immunity in response to foreign RNA such as the toll-like receptors (TLRs) and RIG-I-like receptors (RLRs).


    CLINICAL TRIALS

  • Why did initial Pfizer/Moderna/AZ interim press releases define vaccine efficacy with no follow-up, no reference to time scale?
  • Why have none of the Big Pharma corporations carried out (or published) ongoing analysis of vaccine efficacy – using the trial subjects?
  • Why were the claims of 98%, 95%, 90% efficacy published across the world based on a press release; with no follow up publication of publicly accessible trial data a year after EUA?
  • Why have the vaccine trials and subsequent study data been concealed from peer-review? Why is this legal?

  • &nbsp


    PHASE 3 EFFICACY (NOV-DEC 2020)

    • Pfizer and Moderna showed almost 100% efficacy in press release on abridged phase III trials but real world data revealed much lower efficacy and – after 3-6 months – rapidly decreasing antibody titers
    • Why is the less rapid cliff-edge degradation of non-mRNA vaccines not part of the public conversation?
    • Phase III trial efficacy percentages were extrapolated from, ultimately, just a few dozen cherry-picked subjects and never fully published data
    • How does vaccine efficacy factor in time and viral load, i.e. spending more time coming into contact with SARS-CoV2, being exposed to higher viral load?
    • Vaccine trials pre-published their efficacy numbers after a few weeks phase 3 test subject data
    • Why were there no follow-up on those subjects involved in the various phase 3 trials, no ongoing testing status?
    • Why, almost two years into the pandemic, are the same dysfunctional protocols and the same incomplete data still the best publicly available?


    BOOSTERS?



    “Is there genuine vaccine apartheid in rich versus poor nations? If so, why isn’t anyone breaking the paradigm? Why isn’t self interest in beating pandemic variants should motivation enough?”



      See COVID-19 VACCINE TRACKER (by country)


    Pfizer/Moderna (i.e. NIH patent holder) is not sharing vaccine recipe to protect the mRNA platform – separate to the whole Coronavirus pandemic. The mRNA platform has potential for revenue streams that dwarf the billions in profit from SARS-CoV-2 e.g. it has myriad uses as a cancer delivery drug, which is perhaps the biggest prize in medical science – a bonanza of incalculable trillions that could roll on and on for decades. This is why the patent isn’t going to be shared. It won’t be shared until the technology can be shared in a way that doesn’t open access beyond targeted Coronavirus usage. The vaccine corporations will doubtless be working on a nerfed version. If they find it, there will be a fanfare of “patent sharing”. Gates Foundation (USA) and Wellcome Trust (UK) are key players in this global strategy.



    VACCINE APARTHEID

    • Scientific/academic research and all corporate media/mainstream politics is funded (captured) by the interests of the Gates Foundation and the Wellcome Trust – between them controlling over 60% of funding worldwide
    • Vaccine distribution is mostly under the control of the US (mRNA), the UK (Oxford-AstraZeneca) and India (AstraZeneca), with Russia and China rolling out their own vaccines using homegrown technology
    • US Govt controls Pfizer/BioNtech and Moderna patents through Bayh-Doyle Act because as with over 90% of drug/interventions on the market, the NIH managed the funding of their development including the all-important underlying mRNA technology
    • Oxford University’s Vaccintech spinoff owns the AstraZeneca IP/patent and AstraZeneca is a UK/Swedish corporation so UK government will have a decisive role in sharing (or not) ad-vector patents
    • US public health authorities (NIH, BARDA, CDC, FDA) are directed by the Gates Foundation
    • UK public health authorities (UKHSA, NICE) are directed by the Wellcome Trust
    • EU and India have significant roles in production but probably less relevant in patent control despite BioNtech being a German publicly funded research company
    • India is a major vaccine producer but its nationalist government has expelled the vaccine maker CEOs, hoarding stock for its own people; whose need is great
    • USA and UK are the only autonomous advanced vaccine ecosystems
    • US publishes speeches about benevolent provision but meanwhile aggressively defends conditions of price gouging and monopoly of Pfizer and Moderna over mRNA vaccine tech
    • USA and UK have both horded homeland stock
    • Brookings Institute: Cash and the City – COVID-19 digital social response in Kinshasa, DRC (8-Sept-2021)
    • Covax Misses its 2021 Delivery Target: What’s Gone Wrong in the Fight Against Vaccine Nationalism? (18-Sept-2021)
    • Seguro Popular: Health Coverage For All in Mexico (26-Feb-2015)
  • Cuba Sends 120,000 COVID-19 Vaccines to Syria (9-Jan-2022)


  • DOCUMENTS



    VACCINE PRICING



    NOTES

    • an in silico experiment is one performed via computer simulation – as opposed to in vitro et al. It’s pseudo-Latin for in silico




    ANTIVIRALS – MONOCLONAL ANTIBODIES – ACE2/PROTEASE INHIBITORS



    QUESTIONS

    • Why is Merck putting billions into researching Molnupiravir patented antiviral without putting any resources into studies or proliferating proven safe Ivermectin off-patent antiviral with potential for repurposing against Covid-19?
    • Pharmaceutical companies are about business and profit, quite legitimately
    • Why is government not promoting existing treatments or funding studies – monoclonal antibodies, antiviral drugs (prophylaxis and/or treatment), etc – as a public health duty?
    • Why is government using its authority to push censorship in line with pharmaceutical company profit monopoly including making a fait accompli of emergency use authorisation and maximum profit from patent over off-patent generics?
    • How can protecting corporate (big pharma) profit be more important than safeguarding human life in public health (government) decision making – funding – protocols – authorisations – recommendations – messaging – policy?
    • Merck, developer of general antiviral Ivermectin, announcing late stage human trials for a “new” patent medication and oral antiviral drug for COVID-19 (24-Sept-2021)
    • “Vioxx” is the name is a smear campaign playbook used by Merck Pharmaceuticals to campaign against its own competing drug—the FDA-approved, Nobel prize-winning antiviral Ivermectin, which is generic, cheap and globally available with very little scope for significant profit
    • Merck’s deadly Vioxx playbook redux (7-Sept-2021)


    WORLD HEALTH

    • There are still many nations where vaccines are not yet widely available.
    • There is a gradual shift in focus, to antiviral drugs.
    • Two ways to get new drugs:
      1. Develop novel antiviral drugs for SARS-CoV-2
      2. Repurpose existing FDA-approved drugs to treat COVID-19
    • ANTIVIRAL NOTES
      • Ivermectin (by Merck Pharmaceuticals) is the most studied “repurposed” medication globally in randomized clinical trials, retrospective studies and meta-analyses
      • Molnupiravir and Ivermectin have both demonstrated adjunctive chemoprophylaxis
      • No profit from generic off-patent Ivermectin
      • Funding from Merck (originally from NIH public funding) directed on:
      • New patented medication
      • Marketing Molnupiravir
      • Buying FDA-simpatico studies demonstrating Molnupiravir efficacy
      • Greasing the public health wheels for authorisation e.g. in the UK, US, EU, etc


    NIH EVASION: IVERMECTIN / MONOCLONAL ANTIBODIES

    Much media propagation of the NIH having concluded “there’s currently insufficient data to recommend ivermectin for the treatment of COVID” i.e. don’t use it, don’t explore it. In fact, NIH current status on Ivermectin is there is not enough data to recommend or to discourage its use. NIH recommendation prior to December 2020 was to discourage Ivermectin usage. The change itself is significant and would usually be accompanied by a rush of funds to study its antiviral efficacy. No such funding has been forthcoming.

    Interestingly, two other COVID modalities have exactly the same recommend/discourage status. That would be remdesevir and outpatient monoclonal antibodies. EXACTLY the same status on both of these as ivermectin currently. The NIH states there is not enough evidence to recommend or to discourage the use of either of these. And yet we continue right on with both the others without a blink of an eye.



    A little maths –

    • Ivermectin course for COVID is less than twenty dollars.
    • A course of REMDESEVIR is currently right at 8800 dollars.
    • An outpatient treatment with monoclonal antibodies is right at 23000 – 25000 dollars with all the infusion costs added.

    Eventually, if things keeps looking, smelling and tasting like shit then we have to conclude it is shit.



    ONGOING TRIALS

    • Molnupiravir (Merck)
    • new prodrug antiviral developed by Merck Pharmaceuticals
    • currently in the pipeline for authorisation as a SARS-CoV2 prophylaxis and treatment
    • active treatment of new SARS-CoV-2 infections
    • post-vaccination breakthrough COVID-19 cases
    • authorised in the UK, applications pending USA and Europe
    • Ritonavir (Pfizer)
    • Phase 2/3 trials early completed
    • applying for authorisation


    PHARMODYNAMICS

    • “Molnupiravir is a pro-drug of the novel active antiviral nucleoside analogue … It’s a broad spectrum antiviral agent. … Ivermectin is a broad-spectrum, anti-parasitic, antibiotic and which has demonstrated broad-spectrum antiviral activity”
    • Molnupiravir is a broad spectrum antiviral agent against SARS-CoV-2, SARS-CoV, seasonal or pandemic influenza and MERS coronavirus
    • Ivermectin is an FDA-approved, WHO essential drug used as broad spectrum antiparasitic, antibiotic, and which has demonstrated broad spectrum antiviral activity against RNA viruses, including HIV, Zika, MERS and Coronavirus
    • FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
    • 5000-fold inhibition of SARS-CoV-2, (99.98% at 48 hours)
    • The inhibitory concentration IC50 of Molnupiravir shows it to be an even more potent anti-SARS-CoV-2 agent, compared to Ivermectin in vitro
    • Both Molnupiravir and ivermectin are well absorbed after oral dosing
    • Tmax of Molnupiravir being 1-1.75 hours, with a half life of 7 hours
    • Tmax of Ivermectin is 4-6 hours, very long half life of 81-91 hours
    • Ivermectin, being lipophilic has a large volume of distribution
    • Ivermectin has the ability to accumulate in the lungs where SARS-CoV2 is most dangerously concentrated
    • Anti-SARS-CoV-2 actions of Molnupiravir and Ivermectin are dose and concentration dependent
    • Molnupiravir active metabolite (NHC-5 Triphosphate) acts as a competitive alternative substrate for viral RNA causing viral mutagenesis or mutations, which leads to viral error catastrophe and extinction of replication
    • There is some concern about the safety of NHC -nucleoside triphosphate, which is also mutagenic to mammalian cells
    • Ivermectin, multifarious actions, binding to SARS-CoV-2 spike protein, reducing cell entry via human ACE2 receptors, reducing viral transcription
    • Complimentary pharmacokinetics and pharmacodynamics of the drugs may be additive or synergistic.
    • This should be further investigated in anti-SARS-CoV-2 antiviral combination therapy e.g. a combination of Molnupiravir with Ivermectin putatively, in effects on RdRP or cytokine release


    COST COMPARISONS

    • Cost of Ivermectin package of 100 tablets of 3mg is $2.96, e.g. 12mg per day for 5 days = $0.53
    • Cost of Molnupiravir to be negotiated separately with national health services but US govt initial purchase worked out at $700 for the equivalent 5 day course


    ARTICLES



    MOLNUPIRAVIR



    IVERMECTIN



    PAXLOVID (RITONAVIR)



    ANTIVIRAL DRUG DEVELOPMENT



    IVERMECTIN MESSAGING



    IVERMECTIN STORY

    • Antiviral medication Ivermectin was invented in Japan and mass-produced by Merck
    • Ivermectin is now out of patent, cheap and available worldwide
    • Merck is developing Molnupiravir (MK-4482) as a therapeutic to treat COVID-19 infections
    • Molnupiravir would be an antiviral, like Ivermectin, but patented and therefore potentially worth tens of billions profit versus Ivermectin which is worth nada
    • Molnupiravir is in/recently finished Phase 3 trials
    • Merck received a base award amount of $1.2 billion on 7-Jun-2021 from the Federal Government (1.7 million doses)
    • Molnupiravir is authorised by the UK health authority with authorisation pending in US FDA, EU, Canada and other cracker countries
    • Not surprisingly, Molnupiravir and Ivermectin – both antivirals – have certain similarities with neither showing any serious adverse side effects
    • Merck had the patent on Ivermectin until 1996
    • Molnupiravir has been funded by the US taxpayer (through BARDA) and is on-patent
    • The difference in profit potential may explain why there is so much disparagement of Ivermectin
    • Ivermectin shut out and Molnupiravir widely accepted equals billions USD profit to Merck
    • What I cannot grasp is that for the 10 months when the vaccines were being developed, certain caring, critical care physicians sought out existing drugs and developed protocols
    • Prophylaxis, treatment and containment protocols have been changed many times especially with each new variant
    • The FLCCC Alliance recommends the use Ivermectin as part of more expansive protocols for prophylaxis and treatment of COVID-19 (at all stages) vaccinated or unvaccinated
    • Physicians in the FLCCC Alliance are vilified in the mainstream media but they should be applauded


    AUTHORITARIAN AUSTRALIA

    • Australian government pronounces on Ivermectin via new Australia Medical Association rules for all doctors
    • AMA rules specifically target doctors, restricting their prescribing, rather than citizens who may be buying antivirals on the black market
    • I doubt this new ruling will reduce illegal Ivermectin import
    • If anything the AMA dictates will push doctors and patients further apart, making the latter more likely to resort to self-prescribing, more likely to use social media for dosages, causing worse outcomes
    • Medically honest policy would’ve been to encourage the doctor-patient relationship by not mistrusting the medical experts and not alienating the patients
    • Freeing doctors to do what they’re trained to do saves lives
    • Good doctors are likely to nurture trust in vaccines (by recommending them) while prescribing antivirals or other additional interventions as/when appropriate
    • CHANGE OF POLICY?






     

    INFORMATICS



     

    HEALTH AUTHORITIES

     

    NIH (National Institute of Health)

    NIST (National Institute of Standards and Technology)

    CDC (US Center for Disease Control)

    UKHSA (UK Health Security Agency)

    EIC (European Innovation Council)

    Bill and Melinda Gates Foundation (US Healthcare Charity)

    WELLCOME TRUST (UK Foundation)

    NIAID (National Institute of Allergy and Infectious Diseases)

    BARDA (Biomedical Advanced Research and Development Authority)

     

    GLOBAL CORONAVIRUS CLINICAL TRIALS

     

    WHO: Therapeutics and Covid-19: Living Guideline

    GAVI: Global Vaccine Alliance

    CDC: Latest Vaccine Price List

    Doctors Laboratory: Coronavirus Covid-19 PCR/Antibody Testing

    BCDCC Canada: Covid-19 Vaccine Safety

    Oxford Com-Cov: Oxford Vaccine Group’s Com-Cov Combination Tracking

    Covid-19: Vaccine Tracker (Candidates, Trials, Approvals)

     


     

    GOVERNMENT AGENCIES

     



     

    HETERODOX TRACKERS

     

    ORTHODOX TRACKERS

  • GLOBAL: GISAID – Coronavirus Variant Tracker
  • UK: COVID-19 | NHS Capacity | DAILY VACCINATIONS
  • KFF: COVID-19 Vaccine Use and Reactions Monitor
  • SeroTracker Map: Global Seroprevalence Tracking Dashboard
  • NIKKEI: GLOBAL COVID-19 Vaccinations Tracker
  • WHO Databases: VigiBase | VigiAccess
  •  



    NATIONAL GUIDELINES

     





    R & D

     

    BIG PHARMA

     

    SCIENTISTS

     

    OPEN DATA

     

    UNDERBELLY

    • Public Readiness and Emergency Preparedness Act (PREP) (4-Oct-2021)
        • Note 1. Pursuant to 42 U.S.C. § 247d-6d the federal government “Declaration pursuant to section 319F-3 of the Public Health Service Act to provide liability immunity for activities related to medical countermeasures against COVID-19” provides that “manufacturers” of “any vaccine, used to treat, … prevent or mitigate COVID-19” shall enjoy “[l]iablity immunity ,” including, “from suit and liability under Federal and State law with respect to all claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a [COVID-19 vaccine].”
        • Note 2.  Pursuant to 42 U.S.C. § 247d-6d(c)(5) “If an act or omission by a manufacturer or distributor with respect to a covered countermeasure, which act or omission is alleged under subsection (e)(3)(A) to constitute willful misconduct, … such act or omission shall not constitute ‘willful misconduct’ … if—(i)neither the Secretary nor the Attorney General has initiated an enforcement action with respect to such act or omission; or (ii)such an enforcement action has been initiated and the action has been terminated or finally resolved without a covered remedy.

     



     

    GRIFT

    • DEFUSE PROJECT (22-Sept-2021)

      “Archive exposing timeline of gain-of-function circumvention of laws, appropriation of public funds, US-China secret collaboration and pandemic mishandling”

    • GAVI VACCINE (25-Aug-2021)

      “Scientists around the world are working to produce vaccines that can stop COVID-19 | since the emergence of this novel coronavirus in Dec 2019, 20 vaccines have started to be rolled out in countries worldwide”

    • BBC: TRUSTED NEWS INITIATIVE (10-Dec-2020)

      “Trusted News Initiative (TNI) brought to bear on news and internet media outlets, directed by government, ostensibly to combat so-called disinformation”

    • NIH: NIH VACCINE (25-Jun-2020)

      “NIH has played a critical role in coronavirus research for decades. Federal scientists have helped fund, design, patent and test mRNA-1273 and others; vaccine candidates developed through Moderna and licensed to BioNTech (Germany) partnered with Pfizer Inc”

    • Gain Of Function (19-Dec-2017)

      “National Institutes of Health (NIH) today lifted a 3-year moratorium on funding gain-of-function (GOF) research on potential pandemic viruses such as avian flu, bat coronavirus, SARS, and MERS, opening the door for gain-of-function research to resume”

    • Coronavirus Spike Protein (13-Oct-2017)

      “Prefusion Coronavirus Spike Proteins NIH document – exemplar of going through the motions of appropriating the govt-funded mRNA vaccine technology and corollary patents, to enrich private business interests”

    • Leading US Causes of Death 1999-2014

      “Studying the data about leading causes of death in metro and nonmetro areas of the United States 1999 and 2014 inclusive. Higher rates of death in nonmetropolitan areas (often referred to as rural areas) compared with metropolitan areas have been described”

    • 21st-Century CURES Act (13-Dec-2016)

      “The 21st Century Cures Act (Cures Act), signed into law on December 13, 2016, is designed to help accelerate medical product development and bring new innovations and advances to patients who need them faster and more efficiently – Ahem”

    • ACA Rural Health Insurance (29-Mat-2014)

      “Almost 50 million people (16%) population of the United States, live in rural areas, mainly low-to-moderate-income individuals. 65% of uninsured in rural areas live in States without ACA coverage”

    • Oxford Vaccine Docs Repository (Mar-2020 to Feb-2021)

      “Small repository of documents and links relating to the Oxford University SARS-CoV2 vaccine and Bill Gates Foundation early negotiations”

    • ECOHEALTH ALLIANCE (2014-2019)

      “Ecohealth Alliance Inc (Peter Daszak) ongoing provision of research grant payments for Bat Coronavirus Gain of Function work at the Wuhan Institute of Virology”

    • Dr Peter Daszak (2010-2021)

      “Anonymous “Conspiracy” Dossier on Coronavirus SARS-COV2, Peter Daszak Wuhan Virology, Fauci, the NIH/DARPA/Chinese CP Research Timelines”

    • Impact of Health Insurance on Vaccination Coverage (15-Apr-2015)

      “Underinsurance has been a barrier to vaccination among children. Information on vaccination among adults ≥18 years by insurance status is limited |Purpose: To assess vaccination coverage among adults ≥18 years in the United States in 2012 by health insurance status and access to care characteristics”

    • Truman v AMA (16-Jul-1947)

      “The Challenge of National Healthcare as President Truman takes on the American Medical Association in the aftermath of World War II”

    • The Nuremberg Code (1947)

      “The judgment by the war crimes tribunal at Nuremberg laid down 10 standards to which physicians must conform when carrying out experiments on human subjects in a new code that is now accepted worldwide.

      This judgment established a new standard of ethical medical behaviour for the post World War II human rights era. Amongst other requirements, this document enunciates the requirement of voluntary informed consent of the human subject. The principle of voluntary informed consent protects the right of the individual to control his own body.

      This code also recognizes that the risk must be weighed against the expected benefit, and that unnecessary pain and suffering must be avoided.

      This code recognizes that doctors should avoid actions that injure human patients.

      The principles established by this code for medical practice now have been extended into general codes of medical ethics.”

    • AMERICAN RESCUE PLAN ACT OF 2021 – HARDCOPY
    • The Medical and Scientific Conceptions of Influenza (stanford.edu)
    • IRS: Amounts Paid for Certain Personal Protective Equipment Treated as Medical Expenses (Jul-2021)

     



     

    BIOSECURITY

     

    MILITARY BIOTECH

     

    MILITARY RESEARCH

  • Phase 1 clinical trial of WRAIR-developed COVID-19 vaccine begins (5-Apr-2021)
  • A next-gen Army COVID vaccine you’ve never heard of has just begun human trials (8-Apr-2021)
  • Army to highlight future pandemic preparedness efforts at AUSA (6-Oct-2021)
  • Dr Kayvon Modjarrad on Global Health at Vanderbilt forum (21-Sept-2017)
  • Series of preclinical studies supports the Army’s pan-coronavirus vaccine development strategy (16-Dec-2021)
  • 10% of people on a flight from Miami to Tel Aviv tested positive for COVID-19, despite rules mandating a negative test to fly (21-Dec-2021)
  • Next-Generation Sequencing for Biodefense: Biothreat Detection, Forensics, and the Clinic (1-Mar-2021)
  • A Department of Defense Laboratory Consortium Approach to Next Generation Sequencing and Bioinformatics Training for Infectious Disease Surveillance in Kenya (25-Dec-2020)
  • How Cooperative Engagement Programs Strengthen Sequencing Capabilities for Biosurveillance and Outbreak Response (1-Mar-2021)
  • Towards a genomics-informed, real-time, global pathogen surveillance system (13-Nov-2017)
  • Navy Tests Next Generation Sequencing to Gather DNA Information (6-Aug-2013)
  • Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial (6-May-2020)
  • Combat Infectious Diseases Research Org
  • National Guard Covid Response
  • Oxford University: Anti-cancer drug derived from fungus shows promise in clinical trials (8-Oct-2021)
  • UNC: 3D Printed Vaccine Patch Offers Vaccination Without a Shot (24-Sept-2021)
  •  



     





    American CDC Influenza Data (2018):



    NARRATIVES



    GLOBAL PICTURE



    GOVERNANCE

    • Trump administration (start of pandemic to exit January 2021) incompetent and luddite about Coronavirus messaging (same as Boris Johnson in the UK) – preferring to ignore the early spread, wasting months in stubborn denialism and let Dr Fauci move front and centre
    • Operation Warp Speed (military) brought in by Trump midway through 2020 to husband the developing vaccines to market
    • Organisation of lockdowns, quarantine, public health measures – testing, prophylaxis, vaccine deployment, by-laws – passed to State administrations, coopted by the red-v-blue internecine in the US
    • Genuine divergence of approach between “Establishment” and maverick Trump administration – the former quickly arranged around Dr Fauci and the Democratic Party, proliferating a “Trust The Science” orthodox hegemony as the antidote to Trump/GOP chaos (wilful stupidity)
    • Trillions of dollars transferred from taxpayer revenue to big corporate interests (CARES Act and equivalents in the UK/EU) especially pharma, tech, transport and the military industrial confederacy
    • Manipulated vaccine data, demonisation of the unvaccinated, fearporn focus of media reportage, authoritarian solutions and data obfuscation in official bulletins from Fauci and – once in office – the Biden administration: historically familiar tropes deployed through 21st-century media and tech platform propaganda
    • Under threat of antitrust, Silicon Valley forced into the censorship game – working on behalf of the plutocracy and its official agenda – to silence opposition (dissent) at unprecedented scale including aggressive censorship of anything and anyone diverging from loyal orthodoxy (in the name of duty to best public health outcomes)
    • In typical manufacturing consent fashion, a controlled bullshit spigot of numbers and data and “expert” analysis published 24/7 across the US, UK, Europe and elsewhere about near-perfect efficacy of vaccines, the danger to unvaccinated, the uselessness of prophylaxis, the impossibility of treatment etc
    • Despite the high vaccine efficacy headlined at home, no vaccine program comes together to cover the poorer nations – and thus no possibility of stamping out Coronavirus or preventing new variants from arising
    • Corporate America has emerged wealthier since pandemic start – consolidating, receiving huge taxpayer funds, dropping the economic hit on the middle and working class (e.g. for lockdowns)
    • America’s election (November 2020) removes Trump as a loose cannon as Biden wins Presidency, Democratic Party takes control of the Senate and the House of Reps
    • Progressive opposition is castrated (captured) by corporate politicians while the Democratic Party ensures no disruption to maximising revenue/profit (upward wealth transfer) while hobbling social programs and dispersing leftover energy from 2020 protests like Black Lives Matter


    FUNDING

    • Coronavirus vaccine development – once SARS-CoV2 pandemic was underway – received acceleration funding from two US federal agencies—the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA)
    • Separate channels of American government-military funding (DARPA) and government-civilian science grants (NIH and Fauci) worked out an evolving gain-of-function research collaboration with the Chinese Communist Party and Wuhan Institute of Virology – coordinated by Gates/Wellcome once Trump administration reestablished American support
    • Scientific/academic research and all corporate media/mainstream politics is funded (captured) by the interests of the Gates Foundation and the Wellcome Trust – between them controlling over 60% of funding worldwide
    • US Govt controls Pfizer/BioNtech and Moderna patents through Bayh-Doyle Act because – as with over 90% of drug/interventions on the market – the NIH managed the funding of vaccine platform/tech development including the all-important underlying mRNA technology
    • US public health authorities (NIH, BARDA, CDC, FDA) are directed by the Gates Foundation
    • UK public health authorities (UKHSA, NICE) are directed by the Wellcome Trust

    Pfizer/Moderna (i.e. NIH patent holder) is not sharing vaccine recipe to protect the mRNA platform – separate to the whole Coronavirus pandemic. The mRNA platform has potential for revenue streams that dwarf the billions in profit from SARS-CoV-2 e.g. it has myriad uses as a cancer delivery drug, which is perhaps the biggest prize in medical science – a bonanza of incalculable trillions that could roll on and on for decades. This is why the patent isn’t going to be shared. It won’t be shared until the technology can be shared in a way that doesn’t open access beyond targeted Coronavirus usage. The vaccine corporations will doubtless be working on a nerfed version. If they find it, there will be a fanfare of “patent sharing”. Gates Foundation (USA) and Wellcome Trust (UK) are key players in this global strategy.





    CENSORSHIP

    • Dr Fauci and military Operation Warp Speed work aggressively to keep messaging consistent (and away from scrutiny of Wuhan Institute of Virology). China is also keen to suppress investigation
    • Big Tech is weaponised to censor dissent from any source, scientist or layperson i.e. YouTube, Twitter, Facebook, Google: hand in glove with government mandate
    • Expect censorship to continue, subjects diversifying according to government priority as directed by vaccine makers and political expedience
    • Big tech antitrust regulation is a stick politicians use to beat Silicon Valley corporate platforms into submission – taxation a clear and present penalty, to force corporations and billionaire CEOs into line
    • Expect transgressions that risk profit or power to be punished with increasing force
    • Too much money is flowing and too many powerful people have staked their future on the current strategy of creating a multi-trillion dollar Coronavirus -> Vaccine Biotech Political-Industrial scale-up
    • Expect genuine alternate preventions (prophylaxis) and treatments to be aggressively marginalised – exponents vilified – disloyalty rather than right-or-wrong the litmus for inclusion in the public square
    • Will there be a paradigm shift?
      • Look for testing standards that never coalesce and vaccine approval bias that continue to choose profit over lives
      • Does the American FDA allow no-profit AstraZeneca ad-vector vaccine into the US market?
      • Expect shifting standards in the media shilling for vaccine and vaccine mandates as efficacy data becomes less falsifiable real-world but maximum profit will inform the narrative
      • Messaging will quietly shift if vaccines don’t protect enough i.e. propaganda about extra/regular shots, excuses like “the virus mutated”, “blame the unvaccinated”, “hospital burden”, “efficacy wanes” etc


    MEDIA BULLSHIT SPIGOT



    CORONAVIRUS AT WARPSPEED



    • Gain-of-function banned in the US
    • Moved to Wuhan, China
    • Funded by NIH through Ecohealth (Fauci, Dahsak)
    • Wuhan lab used animals for research, including bats
    • In 2019, a novel coronavirus escaped from the Institute of Virology
    • Evidence of infection at World Military Games 2019
    • Major outbreak spread from Wuhan late 2019/early 2020
    • CCP couldn’t contain it, despite authoritarian lockdown and early suppression
    • SARS-CoV-2 novel coronavirus went worldwide
    • Covid-19, the disease created by SARS-CoV-2, declared pandemic


    NARRATIVE NOTES

    1. Early 2020. World Health Organisation declares pandemic. Coronavirus goes global. China shares viral genetic codes (3 day delay). Chinese scientists from the Wuhan lab register early Covid-19 vaccine patents along with Moderna and BioNtech-Pfizer.
    2. Wet market narrative is inserted. China, WHO, CDC, US Govt and others are in lockstep with an official consensus: accidental coronavirus mutation from animals to humans went pandemic, no lab leak, lockdowns across the world to minimize infections, mass media husband public demand for vaccine ASAP.
    3. There’s no evidence Coronavirus was being weaponized by China or that its escape was planned. There’s plenty of evidence Wuhan lab is the source, gain-of-function conditions bred the initial pandemic variant and China was working directly with America through Ecohealth, a front for the NIH/DARPA, run by Dr Fauci and his delegate Dr Dahsak.
    4. Relative risk reduction and absolute risk reduction measures in the evaluation of clinical trial data are poorly understood by health professionals and the public.
    5. The absence of reported absolute risk reduction in COVID-19 vaccine clinical trials can lead to outcome reporting bias that affects the interpretation of vaccine efficacy.  What’s more, trial data is limited by short time period reporting that don’t take into account increase or decrease in efficacy outside the short window of back to back testing.

    PUBLIC IMPACT


    GAIN OF FUNCTION

    1. Gain-of-function research has a long controversial history and by the time Obama administration signed off on American labs not doing it, EU had also banned it. China has no such restrictions on risky leading edge medical research.
    2. CCP and Chinese military scientists were brought on board. SARS had hit China. The CCP had been working at research already and was keen to benefit from importing state-of-the-art tech + science.
    3. Wuhan Institute of Virology ramped up world leading gain-of-function research and other key internationally sanctioned biological virus science.




    mRNA PLATFORM

    • Development of mRNA technology has been in progress for over 20 years, primarily with a view to opening a new deliver mechanism and drug potential for cancer treatments
    • Decades of money has poured in from many governments but majority from the US Pentagon (DARPA), Gates Foundation (US) and Wellcome Trust (UK) – by far the dominant capital power-centres in the biotech biomed sector
    • Various science hurdles had to be overcome; and NIH funding decisions drove the research in the US
    • UK and Franco-German (EU) government funding equivalents, both importing (licensing) the technology once the patented messenger RNA delivered in lipid shell mechanism was OK’d by US
    • Govt as NIH licensed mRNA tech to careful selections like BioNtech, Moderna, Cellscript and other “Western” biotech corporations
    • While mRNA was originally found to be viable for in vivo gene transfer in the early 1990’s, the development of mRNA vaccines was initiated much later due to the inherent instability of mRNA compared to DNA
    • Coronavirus Vaccine – and underlying platform access – is monopolised by US/UK governments who hold power over Coronavirus treatment regulation (patents) and mass mandate law (policing)
    • Governments ostensibly regulate on behalf of pharmaceutical corporations (profit engines) and health authorities (funding distributors) but ultimately the industry is coordinated by Gates Foundation/Wellcome Trust (source of over 60% global money in all medical and biotech)
    • Biotech and biomedical response to the SARS-CoV-2 virus is part opportunist, part long-term plan forced to execute slightly early: a multi-trillion dollar scale-up (wealth transfer) and consolidation of new centralised power (neoliberal hegemony)


    REGULATORY CAPTURE



    EMERGENCY USE AUTHORISATIONS

    • FDA emergency approval requires there to be no viable available treatment methods. This makes it essential to vaccine profit to squash ANY existing protocol (e.g. ivermectin + steroid + fluvoxamine blend) gaining official recognition
    • Censorship targets “treatment” and “prophylaxis” lines of public discussion consistent with Big Pharma/Big Tech/CDC strategy for maximum vaccine revenue
    • Alternative prophylaxis and treatment protocols for SARS-CoV2 and Covid-19 – like commonplace diet regimens, Vitamin D, weight control, antivirals (ivermectin), monoclonal antibodies – are pushed out of the mainstream and publicly discredited, despite growing evidence and clinician support
    • There’s no profit from off-patent generics
    • Allowing zero profit medication to play a significant role as a Covid-19 treatment – including, in the US, the AstraZeneca vaccine – would reduce mRNA vaccine profits by multi-billions of dollars


    WARPSPEED TRIALS

    • Trials of vaccines begin early/mid 2020 and stages become truncated to get the vaccines into play at unprecedented timescale
    • By Stage III (late 2020) the mRNA vaccine trial studies have been designed from the outset to win FDA authorization and return very high efficacy
    • Authorization of high-profile high-profit vaccines is pushed through fast, to get to market and lock in the billions in sales
    • “Emergency authorization terms require there to be no extant alternative – no other COVID-19 treatment drugs.”
    • Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial (2-Nov-2021)
    • PRESS RELEASES
      • Based on data reported by the manufacturer for Pfzier/BioNTech vaccine BNT162b2, this critical appraisal shows:
        • relative risk reduction, 95.1%; 95% CI, 90.0% to 97.6%; p = 0.016;
        • absolute risk reduction, 0.7%; 95% CI, 0.59% to 0.83%; p < 0.000
      • For the Moderna vaccine mRNA-1273, the appraisal shows:
        • relative risk reduction, 94.1%; 95% CI, 89.1% to 96.8%; p = 0.004
        • absolute risk reduction, 1.1%; 95% CI, 0.97% to 1.32%; p = 0.000ish
      • Unreported absolute risk reduction measures of 0.7% and 1.1% for the Pfzier/BioNTech and Moderna vaccines, respectively, are very much lower than the reported relative risk reduction measures
      • Reporting absolute risk reduction measures is essential to prevent outcome reporting bias in evaluation of COVID-19 vaccine efficacy




    BEATING THE PANDEMIC



    BASICS

    1. Vaccinated people catch Covid and spread it
    2. Vaccine mandate targeting frontline employees does NOT protect workplaces
    3. Antigen (lateral flow) tests cost pennies to manufacture and can be distributed free to everyone, everywhere
    4. Antigen tests specifically answer the question “am I infectious?” in 10 minutes
    5. Home testing lets people isolate if the antigen result is “infectious” before they spread by close contact with anyone else
    6. Knowing if someone is infectious WILL protect workplaces – and at scale it’ll protect society at large


    “The endless obsession with vaccination – whether or not you’re the type who gives a c**p about Big Pharma grift, regulatory capture, faith in govt – is hurting public health. It’s hurting treatment. It’s hurting community trust. It’s hurting testing infrastructure. It’s hurting product competition. It’s poisoning quality of life.”

    The best public health approach to SARS-CoV-2 is a simple TEST-TREAT-PREVENT protocol:



    THREE POINT RESPONSE

    • Universal antigen and community wastewater testing
    • Proactive prophylaxis and unshackled doctor-patient treatment
    • Vaccination based on UP-TO-DATE testing of neutralizing antibody titers i.e. using an individual’s current immunological response to both prior vaccine/s AND prior infection/s
    • No need for lockdowns. No mandates. No one size fits all rules. No apartheid. No travel bans. No unnecessary quarantines. No interfering with doctor patient relationships. No school closure. No masked children. No mass job terminations. No persecution or villifying others


    Why is it so hard to bring in data-driven protocols?

    Why are the simple necessary measures still being debated? Is it honest?

    TEST-TREAT-PREVENT protocols allow corporations make their profit but without compromising public health. It should be a no brainer.





    PORTFOLIO

    0